Makefield Therapeutics, Inc, an emerging therapeutics company, has obtained an exclusive license from Albert Einstein College of Medicine of Yeshiva University to patent applications covering Makefield’s biodegradable Hybrid Nanoparticles, a versatile new drug delivery platform.
(get the story…)

Related items

• Makefield Therapeutics to patent applications covering its Hybrid Nanoparticle drug delivery platform (News-Medical-Net)
• Melanin-covered nanoparticles may protect bone marrow from harmful effects of radiation therapy: Scientists
• Novel nanoparticles prevent radiation damage
• Novel nanoparticles prevent radiation damage (w/ Video)
• Nanoparticles-safe and effective treatment for erectile dysfunction (News-Medical-Net)

Tags: albert einstein college, albert einstein college of medicine, albert einstein college of medicine of yeshiva university, company, einstein college of medicine, Inc, license, Makefield, medicin, medicine, nano, nanoparticle, nanoparticles, patent applications, Therapeutics

This entry was posted on December 22, 2009 at 4:59 am and is filed under Technology.